1. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine;Burns;Proc. Nat. Acad. Sci.,1983
2. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase;Chiba;Biochem. Biophys. Res. Commun.,1984
3. Lowering of epinephrine concentration in rat brain by 2, 3-dichloro-α-methylbenzylamine, an inhibitor of norepinephrine N-methyltransferase;Fuller;Biochem. Pharmacol.,1977
4. Deprenyl protection against striatal dopamine depletion by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice;Fuller;Res. Commun. Subst. Abuse,1984
5. Comparison of the effects of two 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1, 2, 3, 6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1, 2, 3, 6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain;Fuller;J. Pharmacol. Exp. Ther.,1987